IA
NUVB icon

IFP Advisors’s Nuvation Bio NUVB Stock Holding History

IFP Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.15K Sell
1,082
-2,706
-71% -$13.2K ﹤0.01% 3661
2026
Q1 		$16.3K Buy
3,788
+2,689
+245% +$15K ﹤0.01% 2887
2025
Q4 		$9.85K Hold
1,099
– – ﹤0.01% 3075
2025
Q3 		$4.07K Buy
1,099
+884
+411% +$2.41K ﹤0.01% 3360
2025
Q2 		$420 Buy
215
+165
+330% +$344 ﹤0.01% 4483
2025
Q1 		$88 Hold
50
– – ﹤0.01% 3889
2024
Q4 		$133 Buy
+50
New +$129 ﹤0.01% 3923

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

IFP Advisors's NUVB Position: Q2 2026 in Review

IFP Advisors reduced its Nuvation Bio (NUVB) stake by 71% in Q2 2026, selling an estimated $13.2K and leaving 1,082 shares worth $6.15K. The position accounts for ﹤0.01% of the portfolio, ranked #3661.

IFP Advisors first reported a position in NUVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.3K in Q1 2026. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • IFP Advisors held 1,082 shares of Nuvation Bio worth $6.15K as of Q2 2026.
  • IFP Advisors sold 2,706 Nuvation Bio shares in Q2 2026, an estimated $13.2K.
  • Nuvation Bio made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3661 holding.
  • IFP Advisors first reported a position in Nuvation Bio in Q4 2024 and has held it in 7 quarters since.
  • IFP Advisors's Nuvation Bio position peaked at $16.3K in Q1 2026.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.